Industry Research Reports

Home > Reports > Pharma & Healthcare > Tetanus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Tetanus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 106 Pages

Report ld: 2331227

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.

The global market for Tetanus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tetanus Vaccine by region & country, by Type, and by Application.

The Tetanus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine.

Market Segmentation

Report Metric
Details
Report Title
Tetanus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Tetanus Vaccine Companies Covered
GlaxoSmithKline plc, Pfizer,Inc, Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera, Shantha Biotechnics Ltd
Global Tetanus Vaccine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tetanus Vaccine Market, Segment by Type
Diphtheria and tetanus (DT) vaccines

Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines

Tetanus and diphtheria (Td) vaccines

Tetanus, diphtheria, and pertussis (Tdap) vaccines
Global Tetanus Vaccine Market, Segment by Application
Adult

Pediatric
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tetanus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tetanus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Tetanus Vaccine Product Introduction
    1.2 Global Tetanus Vaccine Market Size Forecast
        1.2.1 Global Tetanus Vaccine Sales Value (2019-2030)
        1.2.2 Global Tetanus Vaccine Sales Volume (2019-2030)
        1.2.3 Global Tetanus Vaccine Sales Price (2019-2030)
    1.3 Tetanus Vaccine Market Trends & Drivers
        1.3.1 Tetanus Vaccine Industry Trends
        1.3.2 Tetanus Vaccine Market Drivers & Opportunity
        1.3.3 Tetanus Vaccine Market Challenges
        1.3.4 Tetanus Vaccine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Tetanus Vaccine Players Revenue Ranking (2023)
    2.2 Global Tetanus Vaccine Revenue by Company (2019-2024)
    2.3 Global Tetanus Vaccine Players Sales Volume Ranking (2023)
    2.4 Global Tetanus Vaccine Sales Volume by Company Players (2019-2024)
    2.5 Global Tetanus Vaccine Average Price by Company (2019-2024)
    2.6 Key Manufacturers Tetanus Vaccine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Tetanus Vaccine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Tetanus Vaccine
    2.9 Tetanus Vaccine Market Competitive Analysis
        2.9.1 Tetanus Vaccine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Tetanus Vaccine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diphtheria and tetanus (DT) vaccines
        3.1.2 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
        3.1.3 Tetanus and diphtheria (Td) vaccines
        3.1.4 Tetanus, diphtheria, and pertussis (Tdap) vaccines
    3.2 Global Tetanus Vaccine Sales Value by Type
        3.2.1 Global Tetanus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Tetanus Vaccine Sales Value, by Type (2019-2030)
        3.2.3 Global Tetanus Vaccine Sales Value, by Type (%) (2019-2030)
    3.3 Global Tetanus Vaccine Sales Volume by Type
        3.3.1 Global Tetanus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Tetanus Vaccine Sales Volume, by Type (2019-2030)
        3.3.3 Global Tetanus Vaccine Sales Volume, by Type (%) (2019-2030)
    3.4 Global Tetanus Vaccine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Adult
        4.1.2 Pediatric
    4.2 Global Tetanus Vaccine Sales Value by Application
        4.2.1 Global Tetanus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Tetanus Vaccine Sales Value, by Application (2019-2030)
        4.2.3 Global Tetanus Vaccine Sales Value, by Application (%) (2019-2030)
    4.3 Global Tetanus Vaccine Sales Volume by Application
        4.3.1 Global Tetanus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Tetanus Vaccine Sales Volume, by Application (2019-2030)
        4.3.3 Global Tetanus Vaccine Sales Volume, by Application (%) (2019-2030)
    4.4 Global Tetanus Vaccine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Tetanus Vaccine Sales Value by Region
        5.1.1 Global Tetanus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Tetanus Vaccine Sales Value by Region (2019-2024)
        5.1.3 Global Tetanus Vaccine Sales Value by Region (2025-2030)
        5.1.4 Global Tetanus Vaccine Sales Value by Region (%), (2019-2030)
    5.2 Global Tetanus Vaccine Sales Volume by Region
        5.2.1 Global Tetanus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Tetanus Vaccine Sales Volume by Region (2019-2024)
        5.2.3 Global Tetanus Vaccine Sales Volume by Region (2025-2030)
        5.2.4 Global Tetanus Vaccine Sales Volume by Region (%), (2019-2030)
    5.3 Global Tetanus Vaccine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Tetanus Vaccine Sales Value, 2019-2030
        5.4.2 North America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Tetanus Vaccine Sales Value, 2019-2030
        5.5.2 Europe Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Tetanus Vaccine Sales Value, 2019-2030
        5.6.2 Asia Pacific Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Tetanus Vaccine Sales Value, 2019-2030
        5.7.2 South America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Tetanus Vaccine Sales Value, 2019-2030
        5.8.2 Middle East & Africa Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Tetanus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Tetanus Vaccine Sales Value
        6.2.1 Key Countries/Regions Tetanus Vaccine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Tetanus Vaccine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Tetanus Vaccine Sales Value, 2019-2030
        6.3.2 United States Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Tetanus Vaccine Sales Value, 2019-2030
        6.4.2 Europe Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Tetanus Vaccine Sales Value, 2019-2030
        6.5.2 China Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Tetanus Vaccine Sales Value, 2019-2030
        6.6.2 Japan Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Tetanus Vaccine Sales Value, 2019-2030
        6.7.2 South Korea Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Tetanus Vaccine Sales Value, 2019-2030
        6.8.2 Southeast Asia Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Tetanus Vaccine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Tetanus Vaccine Sales Value, 2019-2030
        6.9.2 India Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Tetanus Vaccine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 GlaxoSmithKline plc
        7.1.1 GlaxoSmithKline plc Company Information
        7.1.2 GlaxoSmithKline plc Introduction and Business Overview
        7.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 GlaxoSmithKline plc Tetanus Vaccine Product Offerings
        7.1.5 GlaxoSmithKline plc Recent Development
    7.2 Pfizer,Inc
        7.2.1 Pfizer,Inc Company Information
        7.2.2 Pfizer,Inc Introduction and Business Overview
        7.2.3 Pfizer,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Pfizer,Inc Tetanus Vaccine Product Offerings
        7.2.5 Pfizer,Inc Recent Development
    7.3 Merck & Co.,Inc
        7.3.1 Merck & Co.,Inc Company Information
        7.3.2 Merck & Co.,Inc Introduction and Business Overview
        7.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Merck & Co.,Inc Tetanus Vaccine Product Offerings
        7.3.5 Merck & Co.,Inc Recent Development
    7.4 Sanofi Pasteur SA
        7.4.1 Sanofi Pasteur SA Company Information
        7.4.2 Sanofi Pasteur SA Introduction and Business Overview
        7.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Sanofi Pasteur SA Tetanus Vaccine Product Offerings
        7.4.5 Sanofi Pasteur SA Recent Development
    7.5 Biological E
        7.5.1 Biological E Company Information
        7.5.2 Biological E Introduction and Business Overview
        7.5.3 Biological E Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Biological E Tetanus Vaccine Product Offerings
        7.5.5 Biological E Recent Development
    7.6 Dano Vaccine &Biological Pvt.Ltd.,
        7.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Information
        7.6.2 Dano Vaccine &Biological Pvt.Ltd., Introduction and Business Overview
        7.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Offerings
        7.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development
    7.7 Panera
        7.7.1 Panera Company Information
        7.7.2 Panera Introduction and Business Overview
        7.7.3 Panera Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Panera Tetanus Vaccine Product Offerings
        7.7.5 Panera Recent Development
    7.8 Shantha Biotechnics Ltd
        7.8.1 Shantha Biotechnics Ltd Company Information
        7.8.2 Shantha Biotechnics Ltd Introduction and Business Overview
        7.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Product Offerings
        7.8.5 Shantha Biotechnics Ltd Recent Development

 8 Industry Chain Analysis
    8.1 Tetanus Vaccine Industrial Chain
    8.2 Tetanus Vaccine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Tetanus Vaccine Sales Model
        8.5.2 Sales Channel
        8.5.3 Tetanus Vaccine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Tetanus Vaccine Market Trends
    Table 2. Tetanus Vaccine Market Drivers & Opportunity
    Table 3. Tetanus Vaccine Market Challenges
    Table 4. Tetanus Vaccine Market Restraints
    Table 5. Global Tetanus Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tetanus Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Tetanus Vaccine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Tetanus Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Tetanus Vaccine Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Tetanus Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Tetanus Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Tetanus Vaccine
    Table 13. Global Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tetanus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Tetanus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Tetanus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Tetanus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Tetanus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Tetanus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Tetanus Vaccine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Tetanus Vaccine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Tetanus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Tetanus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Tetanus Vaccine Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Tetanus Vaccine Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Tetanus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Tetanus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Tetanus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Tetanus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Tetanus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Tetanus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Tetanus Vaccine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Tetanus Vaccine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Tetanus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Tetanus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Tetanus Vaccine Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Tetanus Vaccine Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Tetanus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Tetanus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Tetanus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Tetanus Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Tetanus Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Tetanus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Tetanus Vaccine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Tetanus Vaccine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Tetanus Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Tetanus Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Tetanus Vaccine Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Tetanus Vaccine Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Tetanus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Tetanus Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Tetanus Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Tetanus Vaccine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Tetanus Vaccine Sales Volume, (2025-2030) & (K Units)
    Table 57. GlaxoSmithKline plc Company Information
    Table 58. GlaxoSmithKline plc Introduction and Business Overview
    Table 59. GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. GlaxoSmithKline plc Tetanus Vaccine Product Offerings
    Table 61. GlaxoSmithKline plc Recent Development
    Table 62. Pfizer,Inc Company Information
    Table 63. Pfizer,Inc Introduction and Business Overview
    Table 64. Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Pfizer,Inc Tetanus Vaccine Product Offerings
    Table 66. Pfizer,Inc Recent Development
    Table 67. Merck & Co.,Inc Company Information
    Table 68. Merck & Co.,Inc Introduction and Business Overview
    Table 69. Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Merck & Co.,Inc Tetanus Vaccine Product Offerings
    Table 71. Merck & Co.,Inc Recent Development
    Table 72. Sanofi Pasteur SA Company Information
    Table 73. Sanofi Pasteur SA Introduction and Business Overview
    Table 74. Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Sanofi Pasteur SA Tetanus Vaccine Product Offerings
    Table 76. Sanofi Pasteur SA Recent Development
    Table 77. Biological E Company Information
    Table 78. Biological E Introduction and Business Overview
    Table 79. Biological E Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Biological E Tetanus Vaccine Product Offerings
    Table 81. Biological E Recent Development
    Table 82. Dano Vaccine &Biological Pvt.Ltd., Company Information
    Table 83. Dano Vaccine &Biological Pvt.Ltd., Introduction and Business Overview
    Table 84. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Offerings
    Table 86. Dano Vaccine &Biological Pvt.Ltd., Recent Development
    Table 87. Panera Company Information
    Table 88. Panera Introduction and Business Overview
    Table 89. Panera Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Panera Tetanus Vaccine Product Offerings
    Table 91. Panera Recent Development
    Table 92. Shantha Biotechnics Ltd Company Information
    Table 93. Shantha Biotechnics Ltd Introduction and Business Overview
    Table 94. Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Shantha Biotechnics Ltd Tetanus Vaccine Product Offerings
    Table 96. Shantha Biotechnics Ltd Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Tetanus Vaccine Downstream Customers
    Table 100. Tetanus Vaccine Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tetanus Vaccine Product Picture
    Figure 2. Global Tetanus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Tetanus Vaccine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Tetanus Vaccine Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Tetanus Vaccine Report Years Considered
    Figure 7. Global Tetanus Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Tetanus Vaccine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tetanus Vaccine Revenue in 2023
    Figure 10. Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Diphtheria and tetanus (DT) vaccines Picture
    Figure 12. Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Picture
    Figure 13. Tetanus and diphtheria (Td) vaccines Picture
    Figure 14. Tetanus, diphtheria, and pertussis (Tdap) vaccines Picture
    Figure 15. Global Tetanus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Tetanus Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Tetanus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Tetanus Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Tetanus Vaccine Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Adult
    Figure 21. Product Picture of Pediatric
    Figure 22. Global Tetanus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Tetanus Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Tetanus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Tetanus Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Tetanus Vaccine Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Tetanus Vaccine Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Tetanus Vaccine Sales Volume (%), (2019-2030)
    Figure 39. United States Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 60. Tetanus Vaccine Industrial Chain
    Figure 61. Tetanus Vaccine Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The global market for Tetanus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation